Seventh Annual Clinical Advances in Heart Failure and Arrhythmias
Dr. J. Thomas Heywood spotlights the latest therapies for treating patients with heart failure.
Dr. Ajay V. Srivastava discusses appropriate triaging for patients presenting with signs of cardiogenic shock, heart failure or ventricular failure as well as related treatment strategies.
Dr. Rajeev C. Mohan discusses the World Health Organization (WHO) classifications for pulmonary hypertension and appropriate diagnostic and treatment strategies for each group.
Drs. Heywood, Srivastava and Mohan review real-life cases from their practice and answer questions from course participants (session 1 of 2).
Dr. Douglas N. Gibson discusses stroke prevention strategies for patients with atrial fibrillation as well as currently available antiarrhythmic drug therapy options.
Dr. John D. Rogers provides an update on what’s new in the world of Cardiac Resynchronization Therapy (CRT) devices including benefits for patients and providers.
Drs. Gibson, Olson and Rogers review real-life cases from their practice and answer questions from course participants (session 2 of 2).
Course Overview
Significant advances in the diagnosis and management of heart failure and arrhythmias continue to emerge, compelling the practice of cardiology to constantly evolve. These advances must be consistently implemented into clinical practice to guarantee the best care for patients affected by these cardiovascular conditions. The goal of the conference is for participants to return to their practice equipped with the latest evidence base and practical information to improve patient outcomes.
Educational Objectives
- Incorporate current and emerging clinical evidence in the assessment, treatment and management of patients with challenging cardiovascular disease.
- Apply new concepts in the management of arrhythmias, heart failure and hypertension.
- Discuss the latest diagnosis and treatment options available for cardiac amyloidosis.
- Employ new medical and surgical therapies for heart failure.
- Discuss current pharmacologic and medical management strategies for patients with atrial fibrillation.
- Assess device-based therapies for heart rhythm disorders.